Considerations for cardiac catheterization laboratory procedures during the <scp>COVID</scp>‐19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (<scp><i>SCAI ELM</i></scp>) Members and Graduates

Szerlip, Molly; Anwaruddin, Saif; Aronow, Herbert D.; Cohen, Mauricio G.; Daniels, Matthew J.; Dehghani, Payam; Drachman, Douglas E.; Elmariah, Sammy; Feldman, Dmitriy N.; García, Santiago; Giri, Jay; Kaul, Prashant; Kapur, Navin K.; Kumbhani, Dharam J.; Meraj, Perwaiz; Morray, Brian H.; Nayak, Keshav R.; Parikh, Sahil A.; Sakhuja, Rahul; Schussler, Jeffrey M.; Seto, Arnold H.; Shah, Binita; Swaminathan, Rajesh V.; Zidar, David A.; Naidu, Srihari S.

doi:10.1002/ccd.28887

Cited by 98 publications

(106 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…27 Treatment of ACS in covid-19 should be according to the updated Society for Cardiovascular Angiography and Interventions guidelines. 28 Severe respiratory viral infections can also lead to decreased oxygen delivery to the myocardium via hypoxaemia and vasoconstriction, as well as the haemodynamic effects of sepsis with increased myocardial oxygen demand. This supply and demand mismatch may lead to sustained myocardial ischaemia in patients with underlying coronary artery disease.…”

Section: Ischaemic Myocardial Injury Myocardial Infarctionmentioning

confidence: 99%

Cardiovascular manifestations and treatment considerations in COVID-19

Kang

Chen

Mui

et al. 2020

Heart

331

371

View full text Add to dashboard Cite

Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, covid-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. The cardiovascular interactions of covid-19 have similarities to that of severe acute respiratory syndrome, Middle East respiratory syndrome and influenza. Specific cardiovascular considerations are also necessary in supportive treatment with anticoagulation, the continued use of renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, immunosuppression or modulation, and mechanical circulatory support.

show abstract

Section: Ischaemic Myocardial Injury Myocardial Infarctionmentioning

confidence: 99%

Cardiovascular manifestations and treatment considerations in COVID-19

Kang

Chen

Mui

et al. 2020

Heart

331

371

View full text Add to dashboard Cite

show abstract

“…Guiding principles for structural interventions are similar to those that have been recently proposed for the treatment of patients with acute coronary syndromes. (19) All patients should undergo clinical screening and expedited testing for COVID-19. To minimize the risk of exposure to COVID-19 and to conserve PPE, the treatment team should be limited to essential personnel and should not include trainees.…”

Section: Minimizing the Risk Of Covid-19 Exposure During Structural Hmentioning

confidence: 99%

Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic

Chung

Nazif

Wolbinski

et al. 2020

Journal of the American College of Cardiology

View full text Add to dashboard Cite

Patients with structural heart disease (SHD) are at increased risk of adverse outcomes from the coronavirus disease 19 (COVID-19) due to advanced age and comorbidity. In the midst of a global pandemic of a novel infectious disease, reality-based considerations comprise an important starting point for formulating clinical management pathways. The aim of these "crisisdriven" recommendations is (1) to ensure appropriate and timely treatment of SHD patients, (2) to minimize the risk of COVID-19 exposure to patients and healthcare workers, and (3) to limit resource utilization under conditions of constraint. While the degree of disruption to usual practice will vary across the United States and elsewhere, we hope that early experiences from a Heart Team operating in the current global epicenter of COVID-19 may prove useful for others adapting their practice in advance of local surges of COVID-19.

show abstract

“…[1][2][3] In line with governmental recommendations, 4,5 professional societies, including the American College of Cardiology and Society for Cardiovascular Angiography and Interventions, have recommended deferral of elective cardiac, endovascular, or structural catheterization procedures during the COVID-19 pandemic. 6,7 Beginning even before these directives, NY regional institutions severely restricted elective invasive procedures, including cardiac catheterization. A simultaneous decline in the number of patients presenting with acute coronary syndromes in regions severely affected by the pandemic has also been observed.…”

Section: Introductionmentioning

confidence: 99%

Impact of the COVID‐19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter

Gupta

Nazif

Vahl

et al. 2020

Cathet Cardio Intervent

Self Cite

View full text Add to dashboard Cite

Background: The healthcare burden posed by the coronavirus disease 2019 pandemic in the New York Metropolitan area has necessitated the postponement of elective procedures resulting in a marked reduction in cardiac catheterization laboratory (CCL) volumes with a potential to impact interventional cardiology (IC) fellowship training. Methods:We conducted a web-based survey sent electronically to 21 Accreditation Council for Graduate Medical Education accredited IC fellowship program directors (PDs) and their respective fellows.Results: Fourteen programs (67%) responded to the survey and all acknowledged a significant decrease in CCL procedural volumes. More than half of the PDs reported part of their CCL being converted to inpatient units and IC fellows being redeployed to COVID-19 related duties. More than two-thirds of PDs believed that the COVID-19 pandemic would have a moderate (57%) or severe (14%) adverse impact on IC fellowship training, and 21% of the PDs expected their current fellows' average percutaneous coronary intervention (PCI) volume to be below 250. Of 25 IC fellow respondents, 95% expressed concern that the pandemic would have a moderate (72%) or severe (24%) adverse impact on their fellowship training, and nearly one-fourth of fellows reported performing fewer than 250 PCIs as of March 1st. Finally, roughly one-third of PDs and IC fellows felt that there should be consideration of an extension of fellowship training or a period of early career mentorship after fellowship. Conclusions:The COVID-19 pandemic has caused a significant reduction in CCL procedural volumes that is impacting IC fellowship training in the NY metropolitan area.These results should inform professional societies and accreditation bodies to offer tailored opportunities for remediation of affected trainees.

show abstract

Considerations for cardiac catheterization laboratory procedures during the COVID‐19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates

Cited by 98 publications

References 10 publications

Cardiovascular manifestations and treatment considerations in COVID-19

Cardiovascular manifestations and treatment considerations in COVID-19

Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic

Impact of the COVID‐19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter

Contact Info

Product

Resources

About